LMB vs RARE · P/E 30, rev $312.3M vs rev $350.0M
Limbach Holdings Inc (LMB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Limbach Holdings Inc (LMB) is a building products & equipment company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LMB revenue for 2026-06-30 was $312.3M. Net income was $9.1M. LMB currently screens at market cap $976.2M and trailing P/E 29.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LMB currently screens at market cap $976.2M and trailing P/E 29.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LMB and RARE stock pages for the full models.
Not investment advice.